Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan P Johnson

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|March 28, 2007
Interventions in healthcare-associated infection: researchers urged to CONSORT with ORIONAlan P Johnson, John McConnell
Journal of Medical Microbiology|January 19, 2013
Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistanceAlan P Johnson, Neil Woodford
The Journal of Antimicrobial Chemotherapy|June 26, 2016
Transferable resistance to colistin: a new but old threatStefan Schwarz, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|August 3, 2011
National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the NetherlandsEvelina Tacconelli, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|August 10, 2013
An essential requirement for the licensing of new antibiotics is the provision of data on efficacy and safety obtained from clinical trials in which patients are randomized to receive either the experimental drug or a comparator antibiotic regarded as a standard treatment option. PrefaceAlan P Johnson, Leonard Leibovici
BMJ (Clinical Research Ed.)|August 27, 2017
The prospect of untreatable gonorrhoeaAlan P Johnson, Gwenda Hughes
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Glycopeptide-resistant Staphylococcus aureusAlan P Johnson, Neil Woodford
The Lancet. Infectious Diseases|March 23, 2007
Interventions in health-care-associated infection: researchers urged to CONSORT with ORIONJohn McConnell, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|December 3, 2010
Changes in the classification and management of skin and soft tissue infectionsRoland Koerner, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|May 7, 2011
Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil. PrefaceAlan P Johnson, Leonard Leibovici
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|March 28, 2007
Interventions in healthcare-associated infection: researchers urged to CONSORT with ORIONAlan P Johnson, John McConnell
Journal of Medical Microbiology|January 19, 2013
Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistanceAlan P Johnson, Neil Woodford
The Journal of Antimicrobial Chemotherapy|June 26, 2016
Transferable resistance to colistin: a new but old threatStefan Schwarz, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|August 3, 2011
National guidelines for decolonization of methicillin-resistant Staphylococcus aureus carriers: the implications of recent experience in the NetherlandsEvelina Tacconelli, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|August 10, 2013
An essential requirement for the licensing of new antibiotics is the provision of data on efficacy and safety obtained from clinical trials in which patients are randomized to receive either the experimental drug or a comparator antibiotic regarded as a standard treatment option. PrefaceAlan P Johnson, Leonard Leibovici
BMJ (Clinical Research Ed.)|August 27, 2017
The prospect of untreatable gonorrhoeaAlan P Johnson, Gwenda Hughes
The Journal of Antimicrobial Chemotherapy|October 31, 2002
Glycopeptide-resistant Staphylococcus aureusAlan P Johnson, Neil Woodford
The Lancet. Infectious Diseases|March 23, 2007
Interventions in health-care-associated infection: researchers urged to CONSORT with ORIONJohn McConnell, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|December 3, 2010
Changes in the classification and management of skin and soft tissue infectionsRoland Koerner, Alan P Johnson
The Journal of Antimicrobial Chemotherapy|May 7, 2011
Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil. PrefaceAlan P Johnson, Leonard Leibovici
Pageof 10